News + Filings Transactions
|
Kunkel Lori Anne
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/04/2023 | Nurix Therapeutics, Inc. | NRIX | Grant | Director Stock Option (right to buy) | 25k | $9.44 | $236k | | 05/04/2023 |
| 06/17/2022 | Oric Pharmaceuticals, Inc. | ORIC | Grant | Stock Option (right to buy) | 53.7k | $3.75 | $201.4k | | 06/17/2022 |
| 05/05/2022 | Nurix Therapeutics, Inc. | NRIX | Grant | Director Stock Option (right to buy) | 17.5k | $10.39 | $181.8k | | 05/05/2022 |
| 01/31/2022 | CURIS INC | CRIS | Grant | Non Qualified Stock Option | 85k | $3.19 | $271.2k | | 01/31/2022 |
| 06/16/2021 | Oric Pharmaceuticals, Inc. | ORIC | Grant | Stock Option (right to buy) | 16.6k | $19.03 | $316.4k | | 06/16/2021 |
| 05/06/2021 | Nurix Therapeutics, Inc. | NRIX | Grant | Director Stock Option (right to buy) | 17.5k | $27.38 | $479.2k | | 05/06/2021 |
| 01/28/2021 | CURIS INC | CRIS | Grant | Non Qualified Stock Option | 33k | $9.14 | $301.6k | | 01/28/2021 |
| 06/09/2020 | Oric Pharmaceuticals, Inc. | ORIC | Grant | Stock Option (right to buy) | 28.5k | $35.92 | $1M | | 06/09/2020 |
| 03/02/2020 | CURIS INC | CRIS | Grant | Non Qualified Stock Option | 180k | $1.26 | $226.8k | | 03/02/2020 |
| 05/29/2019 | Forte Biosciences, Inc. | TOCA | Grant | Stock option (right to buy) | 20k | $4.22 | $84.4k | | 05/29/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 27.3k | $3.65 | $99.8k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 49.7k | $3.65 | $181.3k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 4.7k | $20.91 | $98.6k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 3.1k | $24.18 | $74.8k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 11k | $78.58 | $864.4k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 8.8k | $180.98 | $1.6M | | 02/15/2019 |
| 01/23/2019 | CURIS INC | CRIS | Sale | Common Stock | 14.8k | $1.05 | $15.6k | | 01/23/2019 |
| 01/21/2019 | CURIS INC | CRIS | Grant | Non Qualified Stock Option | 180k | $1.16 | $208.8k | | 01/21/2019 |
| 01/11/2019 | Forte Biosciences, Inc. | TOCA | Grant | Stock option (right to buy) | 35k | $9.27 | $324.4k | | 01/11/2019 |
| 10/01/2018 | Loxo Oncology, Inc. | LOXO | Exercise | Director Stock Option (Right to Buy) | 5k | $3.65 | $18.2k | | 10/01/2018 |
| 10/01/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 500 | $171.90 | $85.9k | | 10/01/2018 |
| 10/01/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 4.5k | $170.20 | $765.9k | | 10/01/2018 |
| 06/21/2018 | Forte Biosciences, Inc. | TOCA | Grant | Stock option (right to buy) | 20k | $8.98 | $179.6k | | 06/21/2018 |
| 06/15/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 4 | $177.79 | $711.2 | | 06/14/2018 |
| 06/15/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 1.2k | $175.64 | $216.9k | | 06/14/2018 |
| 06/15/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 5.6k | $177.12 | $992.1k | | 06/14/2018 |
| 06/14/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 28.4k | $180.28 | $5.1M | | 06/14/2018 |
| 06/14/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 2.4k | $181.48 | $437.5k | | 06/14/2018 |
| 06/14/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 1.5k | $182.35 | $281k | | 06/14/2018 |
| 06/14/2018 | Loxo Oncology, Inc. | LOXO | Exercise | Director Stock Option (right to buy) | 27.3k | $3.65 | $99.7k | | 06/14/2018 |
| 06/14/2018 | Loxo Oncology, Inc. | LOXO | Exercise | Director Stock Option (right to buy) | 3.1k | $20.91 | $64.7k | | 06/14/2018 |
| 06/14/2018 | Loxo Oncology, Inc. | LOXO | Exercise | Director Stock Option (right to buy) | 2k | $24.18 | $47.2k | | 06/14/2018 |
| 06/13/2018 | Loxo Oncology, Inc. | LOXO | Grant | Director Stock Option (right to buy) | 8.8k | $180.98 | $1.6M | | 06/13/2018 |
| 04/20/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 4k | $132.81 | $531.2k | | 04/20/2018 |
| 04/20/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 100 | $133.60 | $13.4k | | 04/20/2018 |
|
|